Rapamycin prolongs overall survival and progression-free survival in a mouse model of lung cancer in never smokers resistant to erlotinib Meeting Abstract


Authors: Kawabata, S.; Mercado, J.; Hollander, M. C.; Wilson, W.; Regales, L.; Pao, W.; Janne, P. A.; Wong, K. K.; Dennis, P. A.
Abstract Title: Rapamycin prolongs overall survival and progression-free survival in a mouse model of lung cancer in never smokers resistant to erlotinib
Meeting Title: 102nd Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 71
Issue: 8 Suppl.
Meeting Dates: 2011 Apr 2-6
Meeting Location: Orlando, FL
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2011-04-01
Language: English
ACCESSION: WOS:000209701302368
DOI: 10.1158/1538-7445.am2011-2836
PROVIDER: wos
Notes: Meeting Abstract: 2836 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lucia Regales
    12 Regales